Cholangiocarcinoma Australia
Latest News:
Brenda’s Testimonial
James Hastings Testimonial
Cholangiocarcinoma Foundation Australia Partners with Genomic Focus
The Basics difference between Gem/Cis with Durvalumab vs. Keytruda
PBAC Recommends IMFINZI (durvalumab) for Cholangiocarcinoma Patients in Australia
Steven West: Cholangio Survivor
Lynette Williams: Cholangiocarcinoma Survivor
Cholangiocarcinoma Australia
Latest:
Brenda’s Testimonial
James Hastings Testimonial
Cholangiocarcinoma Foundation Australia Partners with Genomic Focus
The Basics difference between Gem/Cis with Durvalumab vs. Keytruda
PBAC Recommends IMFINZI (durvalumab) for Cholangiocarcinoma Patients in Australia
Steven West: Cholangio Survivor
Lynette Williams: Cholangiocarcinoma Survivor
Bile Gone Bad2024-07-21T19:32:52+12:00
Empower Our Patients – Increase Their Survival.
Empower their Community and Workplaces – Exponentially Increase Survival

“We, work to ensure that today’s research and knowledge are fully utilised and integrated into today’s patient toolkit. By simplifying both the science and the knowledge into a format that patients and caregivers can understand and effectively apply, we help achieve this” ~ Steve Holmes 

Join our updates:

Navigator Journal and Digital Toolkits

Do you have your free Patient Navigator?

Become Part of the Solution

Help by donating to support us ‘researching the research’, identifying and targeting the gaps, and initiating, leading, and supporting studies that benefit today’s patient survival.

If you would like to seek naming rights for the study ‘Is Bile Composition a Cause of Bile Duct Cancer?‘ please contact claire@cholangio.org

Become Part Of The Solution

Was this helpful?  Please help us help patients succeed

World Cholangio Day

20th February 2025 
LIGHT AUSTRALIA GREEN

Projects you are supporting

Optimal Patient Response (OPR)

From Passenger To Co-Pilot: An Initiative and a carefully choreographed process that enhances healthcare by transforming the standard-of-care into a more comprehensive ‘standard-of-response’ process. At its core are printed Patient Navigator Journals and supporting digital web-app suite, all designed to better equip and empower the patients capacity to effectively respond and survive their diagnosis. A clear, step-by-step process supported by CCF peer-trained Navigators, Coaches, Hospital Ambassadors, and a constructive peer-to-peer community, replacing chaos with calm, and overwhelm with direction.

Light Australia Green

Galvanising Collaboration: The Light Australia Green Initiative is a comprehensive annual campaign focused on raising awareness and driving engagement in bile health and cancer response. Through targeted events, such as hospital-hosted symposiums, landmark illuminations on World Cholangiocarcinoma Day, and an annual conference, the initiative unites key stakeholders to promote collaboration, education and progress in managing bile-related cancers.

BILEflow: Bile Health

BILEflow Stands on its own as a research-driven initiative focused on understanding bile composition and health. Aimed at identifying chronic precancerous conditions, thus providing preventive measures for at risk /family and patient monitoring.

BILElink For Patients

Support our CCA-specific BILElink For Patients:  A patient-led, AI-assisted central intelligence platform that matches patient diagnoses with patient-endorsed medical professionals, remote 2nd opinions, remote collaborations, and clinical trials by mutation type.

Cholangiocarcinoma Foundation Australia is registered as a charity with the Australian Charities and Not-for-Profits Commission (ACNC). Cholangiocarcinoma Foundation Australia has Deductible Gift Recipient (DGR) status with the Australian Tax Office. Donations over $2 or more are tax-deductible. ABN: 93 665 038 102

Need to Talk

Need to Talk

+61 415 153 522
steve@cholangio.org
+61 415 153 522
steve@cholangio.org

Shaping The Future

The Empowered Patient is uniquely positioned and equipped to understand, engage, and succeed by utilizing a process that integrates scientific advancements, evidence-based medicine, and human resilience attributes into a comprehensive response strategy.

Fully embracing the concept of an empowered patient will advance science, reshape the healthcare response, and close the unattended gap between early detection and late-stage diagnosis.

Copyright 2017 | All Rights Reserved | Cholangiocarcinoma Foundation Australia

Go to Top